Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4017 for Raised Intra-Ocular Pressure
NCT01173471Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of AZD4017 in ocular hypertension, primary open-angle glaucoma (POAG), sponsored by AstraZeneca. Started Dec 2010; status: completed.
02
Drugs
AZD4017
03
Conditions
ocular hypertensionprimary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT01173471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01173471.